Gelpell® is presently the only delivery system available on the market produced via pharmaceutical grade GMP (good manufacturing practices) to deliver CBD-based health products. The advantage is an even, metered delivery of the CBD contained in these capsules.
Satipharm has acquired the exclusive distribution and marketing rights for this Gelpell® Micro-gel technology for all cannabis-based applications.
Gelpell® Microgel Process
The Gelpell® Microgel process produces gelatin beads which are approximately 2 mm in length and contain a payload of concentrated cannabinoids. The cannabinoids are bound and protected by a three-dimensional natural gelatin matrix. When ingested, the gelatin beads create a micro-emulsion which substantially enhances the oral bioavailability of the cannabinoids, and helps ensure accurate and consistent doses. These beads are encapsulated and packaged under GMP protocols into 10 mg, 50 mg and 100 mg presentations.